Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Observational 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 7Colonic Neoplasms 6Colonic Polyps 4Inflammatory Bowel Diseases 3Surgical Wound Infection 2Rectal Neoplasms 2Neoplasms 2Melanoma 2Carcinoma, Hepatocellular 2Uveal Melanoma 1Sarcoma 1Polyps 1Ovarian Neoplasms 1Opioid-Induced Constipation 1Lymphoma, Non-Hodgkin 1Liver Neoplasms 1Leukemia, Myeloid, Acute 1Intestinal Neoplasms 1Gastrointestinal Hemorrhage 1Diverticulitis 1Colonic Diseases 1Cancer Pain 1Adenoma 1

Interventions

Irinotecan 4Oxaliplatin 3Bevacizumab 3trimebutine 3-thiocarbamoylbenzenesulfonate 2pembrolizumab 2Leucovorin 2Fluorouracil 2Drug Therapy 2Cyclophosphamide 2Cetuximab 2Capecitabine 2Aspirin 2Ascorbic Acid 2repotrectinib 1pralsetinib 1napabucasin 1ibrutinib 1guadecitabine 1encorafenib 1alectinib 1XELOX 1Sutures 1Surgical Instruments 1Polyethylene Glycols 1Optical Imaging 1Ocoxin 1Levoleucovorin 1KRN-330 1Diagnosis 1Control Groups 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Colonic Diseases × Polyethylene Glycols × Clear all
NCT05174845 2022-05-31

Real Word Evidence With 1L Polyethylene Glycol (PEG)+ Ascorbic Acid in Iberia

Norgine

Completed
13,393 enrolled
Gastrointestinal

Colonic Diseases, Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡